The invention relates to a device for treating an individual suffering from cardiac or circulatory arrest or from a stroke, comprising a blood withdrawal device (BE) that is applied to the individual (P), an analysis unit (BA) which is directly or indirectly connected to the blood withdrawal device for detecting a blood analysis result (BAE) providing at least one characteristic of the blood, directly or indirectly connected to a blood return device (BR) that is applied to the individual (P) and is designed to deliver a substance to the individual via the return device (BR).

Methods, systems, and devices for the delivery of a therapeutic using a catheter are provided. Many embodiments are directed to a catheter with one or more lumens that can be used to deliver a therapeutic to a tumor. Many embodiments include an occlusion mechanism that can block off downstream vasculature to prevent damage to normal or healthy tissue caused by the therapeutic. Numerous embodiments are used to deliver a bolus of Yttrium-90 microspheres to a tumor. Also provided are methods of using such catheters.

The invention relates to a device for treating an individual suffering from cardiac or circulatory arrest or from a stroke, comprising a blood withdrawal device (BE) that is applied to the individual (P), an analysis unit (BA) which is directly or indirectly connected to the blood withdrawal device for detecting a blood analysis result (BAE) providing at least one characteristic of the blood, directly or indirectly connected to a blood return device (BR) that is applied to the individual (P) and is designed to deliver a substance to the individual via the return device (BR).

A blood reintroduction system can include a canister having a chamber configured to collect blood. A system may include an inlet configured to fluidically connect the chamber to a first tubing in fluid communication with an aspiration catheter. A system may include a first filter within the chamber, wherein the first filter is configured to separate blood from thrombus. A system may include a second filter downstream of the first filter, wherein the second filter is configured to separate blood from thrombus. A system may include a second tubing connected to an outlet of the chamber, wherein the second tubing is configured to reintroduce filtered blood from the chamber to a patient's vasculature.

Vascular treatment devices and methods include a woven structure including a plurality of bulbs that may be self-expanding, a hypotube, for example including interspersed patterns of longitudinally spaced rows of kerfs, and a bonding zone between the woven structure and the hypotube. The woven structure may include patterns of radiopaque filaments measureable under x-ray. Structures may be heat treated to include various shapes at different temperatures. The woven structure may be deployable to implant in a vessel. A catheter may include a hypotube including interspersed patterns of longitudinally spaced rows of kerfs and optionally a balloon. Laser cutting systems may include fluid flow systems.

A drug dosage form is provided in the form of a solid tablet which is greater than 50% by weight the local anesthetic agent. The local anesthetic agent may be selected from the group consisting of an aminoamide, an aminoester, and a combination thereof. The drug tablet may be in the form of a mini-tablet which is greater than 70 wt % drug, with the balance being excipient. For example, the anesthetic agent may include lidocaine, in a salt or base form, combined with binder and lubricant excipients. Implantable drug delivery devices including the tablets are also provided, e.g., one or more of the drug tablets may be contained in a biocompatible housing. The drug tablets may be substantially cylindrical with flat end faces, and the device may have from 10 to 100 drug tablets aligned in the housing with the flat end faces of adjacent tablets abutting one another.

A catheter system for draining a fluid from a bladder. The system includes a catheter combined with an amount of chlorine dioxide adapted to reduce infection in catheter associate urinary tract infections. The chlorine dioxide is adapted for use with at least one of a hydrophilic coating on an outer surface of the catheter, a wetting fluid that interacts with the hydrophilic coating and a lubricant in contact with the outer surface of the catheter.

An extension assembly including a connector assembly and a hose. The connector assembly includes a housing, a test strip and a hose coupling. The test strip is positionable within the housing, with a portion of the hose coupling insertable into the housing so as to sandwich the test strip therebetween, with a portion of the test strip exposed to the bore of the connector assembly.

Disclosed herein are embodiments of an electric suction device for emergency airway obstruction removal and anti-choking, relating to the field of emergency rescue technology. One embodiment comprises a face mask, with an electric suction mechanism set on the surface of the face mask. The electric suction mechanism includes an oral support that is movably installed inside the face mask. The face mask is pressed tightly against the face and adjusted to form a sealed space. Activating the electric suction mechanism switch triggers the control circuit board to power the one-way suction module via the battery. This controls the one-way suction module to extract air, creating negative pressure in the sealed space. Consequently, the obstructing object is suctioned out of the airway due to continuous negative pressure. When the patient is unconscious or unable to cooperate, the oral support can be inserted into the patient's mouth to ensure that the patient's mouth is open and the device can be used. This device is easy to operate, safe and stable. The suction of this device can be controlled and there are different types of masks that can be configured to meet different people. It can be used independently by the patient without third-party assistance, or by a rescuer when the patient is unable to perform self-rescue.

A capsule may include a housing, an aerosol-forming substrate, and a heater. The housing defines inlet openings, outlet openings, and a chamber between the inlet openings and the outlet openings. The chamber may have a longest dimension extending from at least one of the inlet openings to a corresponding one of the outlet openings. The aerosol-forming substrate is within the chamber of the housing. The heater is embedded in the housing. The heater includes a first end section, an intermediate section, and a second end section. The intermediate section is disposed within the aerosol-forming substrate in the chamber. An aerosol-generating device may include a device body with a lid configured to open to permit an insertion of the capsule and configured to close to engage the capsule within the device body.